Dylan Mulvaney's Olay controversy explained as netizens boycott brand online

August 2024 ยท 4 minute read

Trans activist and influencer Dylan Mulvaney is facing the wrath of right-wing critics yet again as her recent Olay advertisement went viral.

Following the Nike and BudLight controversy, netizens dug up an earlier marketing campaign by the activist. The Olay advertisement, which debuted in early March 2023, features Mulvaney getting ready for the day and using Olay SPF moisturizer.

Recently, many top brands, including Nike, Kate Spade, and Kitchen Aid, have partnered with her to promote their products. The YouTuber has been under close scrutiny by anti-trans campaigners since she uploaded a sponsored post on Instagram for BudLight.

Many have demanded a boycott of any product or brand that features her, and some have been digging through her profile and archived posts just to share a list of products not to use.

While there is no clear reason for the backlash against the transgender activist and the brands sponsoring her, Dylan Mulvaney seems to have become a target for the debate against trans rights and trans identity.

Netizens are unimpressed by the numerous marketing deals scored by Dylan Mulvaney.

A comment boycotting Olay (Image via Twitter /@neenie19761)

Trigger Warning: This article contains written and graphic references to transphobic comments shared on Twitter. Reader discretion is advised.

"This has to be a parody": Internet users react to Dylan Mulvaney's advertisement for Olay

As Dylan Mulvaney's earlier advertisement for Olay went viral, netizens were left appalled at the sheer number of brands sponsoring her. Many have been calling for a mass boycott of the brands so that they face a loss. They have shared their tweets with the hashtag #GoWokeGoBroke.

They remarked that the company was "erasing" and disrespecting women, and refused to support the brand.

A comment boycotting Olay (Image via Twitter /@sirli0) A comment boycotting Olay (Image via Twitter /@mosiememphis)

British Influencer, Oil London, has been a key critic of Mulvaney. He stated:

"Dylan Mulvaney stars in new Olay advert, appearing in an ad with women and advertising a women's skincare product! Another brand that has no respect for their customers- women! #GoWokeGoBroke #dylanmulvaney"
A comment boycotting Olay (Image via Twitter /@OilLondonTV)

Here are some comments seen on Twitter:

A comment boycotting Olay (Image via Twitter /@Scandalforlife) A comment boycotting Olay (Image via Twitter /@_AspektEins) A comment boycotting Olay (Image via Twitter /@MargaretLaVecc1)
A comment boycotting Olay (Image via Twitter /@TPAction_) A comment boycotting Olay (Image via Twitter /@RealJackBee)

Dylan Mulvaney is known for her TikTok videos documenting her transition and her video series, Days of Girlhood. Last year, she underwent Facial Feminization Surgery.

Additionally, she is praised for her upbeat and positive attitude and her sweet personality.

Despite the topic gaining traction and the growing debate, Mulvaney has refrained from participating in the conversation or the ensuing drama. However, she continues to share her usual content on social media platforms.

Quick Links

More from Sportskeeda

" modalPopup.closeOnEsc = false; modalPopup.setHeader("Why did you not like this content?"); modalPopup.setContentText(modalText); modalPopup.addCancelOkButton("Submit", resetRatingAndFeedbackForm, sendRating); modalPopup.removeCloseModalIcon(); modalPopup.disableDismissPopup(); modalPopup.open(); } else { sendRating(index); } } function sendRating() { var requestPayload = { "post_id": 1466225, "rating_value": ratingValue } if (ratingValue > 3) { requestPayload.rating_feedback_type = null; requestPayload.rating_feedback = null; } else { if (!$('input[name="drone"]:checked') || !$('input[name="drone"]:checked').value) { showErrorMessage('option'); return; } if (!$(".post-rating-feedback-note textarea") || !$(".post-rating-feedback-note textarea").value) { showErrorMessage('note'); return; } var selectedOption = $('input[name="drone"]:checked').value; var feedbackNote = $(".post-rating-feedback-note textarea").value; requestPayload.rating_feedback_type = selectedOption; requestPayload.rating_feedback = feedbackNote; } pureJSAjaxPost(addratingAPI, requestPayload, onsaveRatingSuccess, onsaveRatingFail, function() {}, true); } function resetRatingAndFeedbackForm() { var activeStars = Array.from($all('.rating span.rating-star.active')); for (var i=0; i < activeStars.length; i++) { activeStars[i].classList.remove("active"); } if ($('input[name="drone"]:checked')) { $('input[name="drone"]:checked').checked = false; } var userNote = document.querySelector(".post-rating-feedback-note textarea"); userNote.value = ''; modalPopup.close(); } function onsaveRatingSuccess() { modalPopup.close(); savePostIdInUserRatedPostsCookie(); $("#post-rating-layout").classList.add("hidden"); $("#post-rating-message").classList.remove("hidden"); window.setInterval(function showMessage() { $("#post-rating-widget").classList.add("hidden"); }, 3000); } function onsaveRatingFail() { console.error('Saving post rating failed!'); modalPopup.close(); } function savePostIdInUserRatedPostsCookie() { userRatedPostIds.push(1466225); var expiryTime = new Date(); expiryTime.setMonth(expiryTime.getMonth() + 12); // Expiry after 1 year setCookie("user_rated_post_ids", JSON.stringify(userRatedPostIds), expiryTime); } function isPostRatedByUser() { var userRatedPostIds = getCookie('user_rated_post_ids'); if (userRatedPostIds) { try { userRatedPostIds = JSON.parse(userRatedPostIds); } catch (err) { console.error(err); return false; } } else { return false; } if(userRatedPostIds.indexOf(1466225) >= 0) { return true; } else { return false; } } function getRatingCountByPostId(postId) { return new Promise(function(resolve, reject) { pureJSAjaxGet( getRatingCountBaseURL + postId + '/rating/count', function(data) { try { data = JSON.parse(data); if (data.meta_value) { resolve(data.meta_value); } reject("Failed to fetch rating count for the post:" + postId); } catch (err) { reject("Failed to fetch rating count for the post:" + postId); } }, function(err) { reject("Failed to fetch rating count for the post:" + postId); }, true); }); } function showErrorMessage(messageType) { var messageContainerId = '#' + messageType + '-error'; $(messageContainerId).classList.remove('hidden'); window.setInterval(function () { $(messageContainerId).classList.add("hidden"); }, 5000); } (function() { var callFired = false; function lazyLoadPostRating() { if (callFired) return; callFired = true; if (!isPostRatedByUser()) { getRatingCountByPostId(1466225) .then(function(ratingCount) { if (ratingCount < 10) { $("#post-rating-widget").classList.remove("hidden"); } }) .catch(function(err){ console.error(err); }); } } document.addEventListener("scroll", lazyLoadPostRating, { passive: true, once: true }); document.addEventListener("mousemove", lazyLoadPostRating, { passive: true, once: true }); document.addEventListener("touchmove", lazyLoadPostRating, { passive: true, once: true }); })();

ncG1vNJzZmivp6x7tLzOq6uso5WasaJ6wqikaKifpXqkwcutrKudX5a7sMDHnqlmmqKWu6V5yGauoqScYrmwusaeqWaapa56pcXLmqVmpaWhw6K6xLJkrGWfoa66ecKopa2qn6uys7%2FYZpyxqJyWtq%2Bxw2alnqyZr7Kvv4ybprKbn6nBbq7RmqWdZZ%2Bjuaq6xA%3D%3D